Transmissible Spongiform Encephalopathy in the 21st Century: Neuroscience for the Clinical Neurologist
Authors
Affiliations
Nelson P, Dickson D, Trojanowski J, Jack C, Boyle P, Arfanakis K Brain. 2019; 142(9):e48.
PMID: 31359039 PMC: 6931389. DOI: 10.1093/brain/awz226.
Coulthart M, Jansen G, Cashman N CMAJ. 2014; 186(9):E333-9.
PMID: 24446456 PMC: 4050025. DOI: 10.1503/cmaj.130720.
Could immunomodulation be used to prevent prion diseases?.
Wisniewski T, Goni F Expert Rev Anti Infect Ther. 2012; 10(3):307-17.
PMID: 22397565 PMC: 3321512. DOI: 10.1586/eri.11.177.
Interaction between pathogenic proteins in neurodegenerative disorders.
Jellinger K J Cell Mol Med. 2011; 16(6):1166-83.
PMID: 22176890 PMC: 3823071. DOI: 10.1111/j.1582-4934.2011.01507.x.
Styryl-based and tricyclic compounds as potential anti-prion agents.
Chung E, Prelli F, Dealler S, Lee W, Chang Y, Wisniewski T PLoS One. 2011; 6(9):e24844.
PMID: 21931860 PMC: 3172287. DOI: 10.1371/journal.pone.0024844.